For MAL2, we found that, while high gene expression is linked to shorter survival in 4 cancer types (pancreatic ductal adenocarcinoma, uveal melanoma, thymoma and uterine corpus endometrial carcinoma), it is linked to better survival in bladder urothelial and head and neck squamous cell carcinoma. The gene discussed is MAL2; the disease is uterine corpus endometrial carcinoma.